GTBIF
Price
$8.92
Change
+$0.09 (+1.02%)
Updated
Aug 26 closing price
Capitalization
2.07B
JUSHF
Price
$0.77
Change
+$0.05 (+6.94%)
Updated
Aug 26 closing price
Capitalization
147.91M
83 days until earnings call
Interact to see
Advertisement

GTBIF vs JUSHF

Header iconGTBIF vs JUSHF Comparison
Open Charts GTBIF vs JUSHFBanner chart's image
Green Thumb Industries
Price$8.92
Change+$0.09 (+1.02%)
Volume$897.12K
Capitalization2.07B
Jushi Holdings
Price$0.77
Change+$0.05 (+6.94%)
Volume$1.03M
Capitalization147.91M
GTBIF vs JUSHF Comparison Chart in %
Loading...
GTBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JUSHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GTBIF vs. JUSHF commentary
Aug 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTBIF is a StrongBuy and JUSHF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 27, 2025
Stock price -- (GTBIF: $8.92 vs. JUSHF: $0.77)
Brand notoriety: GTBIF and JUSHF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: GTBIF: 146% vs. JUSHF: 306%
Market capitalization -- GTBIF: $2.07B vs. JUSHF: $147.91M
GTBIF [@Pharmaceuticals: Generic] is valued at $2.07B. JUSHF’s [@Pharmaceuticals: Generic] market capitalization is $147.91M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GTBIF’s FA Score shows that 1 FA rating(s) are green whileJUSHF’s FA Score has 0 green FA rating(s).

  • GTBIF’s FA Score: 1 green, 4 red.
  • JUSHF’s FA Score: 0 green, 5 red.
According to our system of comparison, both GTBIF and JUSHF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GTBIF’s TA Score shows that 4 TA indicator(s) are bullish while JUSHF’s TA Score has 6 bullish TA indicator(s).

  • GTBIF’s TA Score: 4 bullish, 4 bearish.
  • JUSHF’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, JUSHF is a better buy in the short-term than GTBIF.

Price Growth

GTBIF (@Pharmaceuticals: Generic) experienced а +20.58% price change this week, while JUSHF (@Pharmaceuticals: Generic) price change was +47.37% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.09%. For the same industry, the average monthly price growth was +10.13%, and the average quarterly price growth was +77.76%.

Reported Earning Dates

JUSHF is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.09% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GTBIF($2.07B) has a higher market cap than JUSHF($148M). JUSHF YTD gains are higher at: 147.588 vs. GTBIF (9.180). GTBIF has higher annual earnings (EBITDA): 338M vs. JUSHF (44.8M). GTBIF has more cash in the bank: 177M vs. JUSHF (23.2M). JUSHF has less debt than GTBIF: JUSHF (269M) vs GTBIF (523M). GTBIF has higher revenues than JUSHF: GTBIF (1.15B) vs JUSHF (256M).
GTBIFJUSHFGTBIF / JUSHF
Capitalization2.07B148M1,397%
EBITDA338M44.8M754%
Gain YTD9.180147.5886%
P/E Ratio81.09N/A-
Revenue1.15B256M451%
Total Cash177M23.2M763%
Total Debt523M269M194%
FUNDAMENTALS RATINGS
GTBIF vs JUSHF: Fundamental Ratings
GTBIF
JUSHF
OUTLOOK RATING
1..100
1922
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
49
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
90100
PRICE GROWTH RATING
1..100
3835
P/E GROWTH RATING
1..100
9100
SEASONALITY SCORE
1..100
4475

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

JUSHF's Valuation (49) in the null industry is somewhat better than the same rating for GTBIF (83). This means that JUSHF’s stock grew somewhat faster than GTBIF’s over the last 12 months.

JUSHF's Profit vs Risk Rating (100) in the null industry is in the same range as GTBIF (100). This means that JUSHF’s stock grew similarly to GTBIF’s over the last 12 months.

GTBIF's SMR Rating (90) in the null industry is in the same range as JUSHF (100). This means that GTBIF’s stock grew similarly to JUSHF’s over the last 12 months.

JUSHF's Price Growth Rating (35) in the null industry is in the same range as GTBIF (38). This means that JUSHF’s stock grew similarly to GTBIF’s over the last 12 months.

GTBIF's P/E Growth Rating (9) in the null industry is significantly better than the same rating for JUSHF (100). This means that GTBIF’s stock grew significantly faster than JUSHF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GTBIFJUSHF
RSI
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
88%
Declines
ODDS (%)
Bearish Trend 13 days ago
85%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
GTBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JUSHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRWAX81.55N/A
N/A
T. Rowe Price All-Cap Opportunities Fund
SIDVX13.01N/A
N/A
Hartford Schroders Intl Multi-Cp Val A
AQEIX18.80N/A
N/A
LKCM Aquinas Catholic Equity
FRLCX13.81N/A
N/A
Nuveen Real Estate Securities C
HSLCX40.57N/A
N/A
Hartford Small Cap Growth C

GTBIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GTBIF has been closely correlated with TCNNF. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if GTBIF jumps, then TCNNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GTBIF
1D Price
Change %
GTBIF100%
+1.04%
TCNNF - GTBIF
83%
Closely correlated
+4.09%
CURLF - GTBIF
82%
Closely correlated
+5.62%
VRNOF - GTBIF
80%
Closely correlated
+3.66%
TSNDF - GTBIF
78%
Closely correlated
+6.48%
CRLBF - GTBIF
71%
Closely correlated
+5.30%
More

JUSHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, JUSHF has been closely correlated with TCNNF. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if JUSHF jumps, then TCNNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JUSHF
1D Price
Change %
JUSHF100%
+6.50%
TCNNF - JUSHF
74%
Closely correlated
+4.09%
CRLBF - JUSHF
74%
Closely correlated
+5.30%
CURLF - JUSHF
72%
Closely correlated
+5.62%
TSNDF - JUSHF
71%
Closely correlated
+6.48%
GTBIF - JUSHF
70%
Closely correlated
+1.04%
More